Antipsychotic likely to increase mortality risk in dementia residents, study finds

Share this article:

Nursing home residents being treated for dementia with the antipsychotic drug haloperidol were at a two-fold risk of mortality compared to other antipsychotics, a new study finds.

The use of antipsychotics to treat dementia is controversial in nursing homes, and regulators have raised the alarm about the increased risk of death in residents taking them. Reducing the off-label use of antipsychotics is a top priority of some provider groups.

In an attempt to determine which antipsychotics are more problematic, researchers from Harvard evaluated the mortality risk of several antipsychotic drugs in 75,445 nursing home residents who were over the age of 65. In addition to haloperidol, the investigators studied the mortality rates of aripiprazole, olanzapine, quetiapine, risperidone and ziprasidone.

After controlling for factors such as residents' ethnicity, age and gender, as well as the facility's size, occupancy rate and other factors, the researchers determined that risk for mortality varies from medication to medication, but that haloperidol had a higher risk. 

The study was published online in BMJ.
Share this article:

More in News

Profile: AHCA's money player

Profile: AHCA's money player

If there's a prevailing theme around the hours American Health Care Association senior fellow Elise Smith keeps, it's that they are constant.

Residents cheer tractor parade

Residents cheer tractor parade

Many residents of the Oskaloosa Care Center in southern Iowa used to be farmers. They're reminded of their past by the cornfield next to the nursing home — and, once ...

No need for injury

No need for injury

Due to dynamic factors in moving residents, facilities must invest wisely in lifts, slings and batteries to make sure workers stay safe while performing transfers